ALGN vs LMAT
Align Technology vs LeMaitre Vascular, Inc. — AI-powered side-by-side comparison
ALGN
Align Technology
73
Buy
VS
LMAT
LeMaitre Vascular, Inc.
57
Watch
| Metric | ALGN | LMAT |
|---|
| AI Score |
73
|
57
|
| Price |
$172.86
|
$82.83
|
| P/E Ratio |
30.03×
|
28.57×
|
| ROE |
10.1%
|
14.7%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
66.5%
|
72.9%
|
| Debt / Equity |
0.03×
|
0.45×
|
| Dividend Yield |
0.0%
|
1.1%
|
| RSI (14) |
55.1
|
31.2
|
| Beta |
1.653
|
0.524
|
| Expected Upside |
+7.7%
|
—
|
AI Committee View
Current Innellis committee reasoning for ALGN versus LMAT.
ALGN leads by 16 points.
ALGN scores 73/100 (Buy) versus LMAT at 57/100 (Watch).
ALGN Committee View
100% agreement
5 analysts
The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is 2 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
LMAT Committee View
50% agreement
6 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 38.2% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- ROE of 16.4% shows genuine earnings power backing the valuation — Value
- EPS growing 34.4% YoY — Growth
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- P/E of 28.6 is moderate-to-rich — Value
- Price-to-book of 4.7x prices in significant intangible value — Value
- MACD histogram negative -- bearish momentum — Technical